VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Mar 12, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-03-09

Reporting Person: WINGER DENNIS L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-09	Common Stock	A	18750	$34.05	Acquired	25250	Direct
2012-03-09	Common Stock	A	20000	$34.24	Acquired	45250	Direct
2012-03-09	Common Stock	D	38750	$41.65	Disposed	6500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-09	Stock Option	$34.05	M	18750	Disposed	2019-07-05	Common Stock (18750)	Direct
2012-03-09	Stock Option	$34.24	M	20000	Disposed	2020-05-31	Common Stock (20000)	Direct

Footnotes

F1: Open market sales reported on this line occurred at a weighted average price of $41.65 (range $41.61 to $41.74).

F2: Mr. Winger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3: Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments over four years.

F4: Fully vested.